HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

884.420

+5.9320.68%

Number of Gainers:11

Number of Losers:5

Number of Flat:1

PE:- -

High:889.395

Open:878.433

Low:868.104

Close:878.487

Volume:252.66M

Turnover:1.88B

Market Cap:597.22B

Float Cap:494.80B

Loading ...

DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'

Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts

Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B

Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug

MT Newswires Live

Baiyunshan Announces Cash Dividend Distribution for First Half of 2026

Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors

Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 "Gpc3 ADC" Approved by FDA

THOMSON REUTERS

Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase

GENFLEET-B Allocates HK$546,400 to Buy Back 20,000 Shares on September 3

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China

THOMSON REUTERS

Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets

CSPC Pharmaceutical Group Stock Climbs 4.8% in Hong Kong

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

BYD Electronic (International) Stock Falls 3.1% in Hong Kong

Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug

AH Premium Rankings Update: September 3 Market Close

BYD Electronic Could See Earnings Inflection in 2027

Clinical Data Readouts Take Center Stage as Chinese Biotech Firms Surge; CSPC Pharma Climbs Over 4% While Huabao's HK Biotech ETF Holds Key Support

SBP Group Surges Over 4% in Morning Trade on FDA Clearance for TQB6426

CanSino Biologics' Global Revenue Soars 4,724% in First Half, Systemic Expansion Strategy Unlocks Growth Potential

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK1515/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":884.4196,"timestamp":1789632487194,"preClose":878.48724,"halted":0,"volume":252663133,"delay":0,"changeRate":0.006753,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":5.932373,"latestTime":"09-17 16:00:00","open":878.4325,"high":889.39496,"low":868.10425,"amount":1880494933,"amplitude":0.024236,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":1.317311,"peRate":17.071131,"turnoverRate":0.003313,"increases":11,"decrements":6,"flats":0,"marketCap":597221994560,"floatMarketCap":494797907072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":889.39496,"amplitude":0.024236,"preClose":878.48724,"low":868.10425,"pbRate":"1.317311","latestPrice":884.4196,"volume":252663133,"delay":0,"open":878.4325,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":890.408,"twentyDayClose":941.274,"sixtyDayClose":813.549,"secType":"PLATE","market":"HK","turnoverRate":0.003313,"peRate":17.071131,"marketCap":597221994560,"floatMarketCap":494797907072,"timestamp":1789632487194,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":11,"down":5,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1130149343","title":"DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=1130149343","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130149343?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:26","pubTimestamp":1788510375,"startTime":"0","endTime":"0","summary":"DBS has released a research report stating it has raised the target price for BYD Electronic (00285) from HK$30 to HK$40, while maintaining a \"Buy\" rating. The bank has extended its valuation base to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1540","LU0348766576.USD","BK1582","BK1504","BK1607","BK1149","EWH","BK1589","00285","BK1515","LU0348767384.USD","LU0274383008.USD","BK1167","BK1580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183163431","title":"Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1183163431","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183163431?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:16","pubTimestamp":1788506182,"startTime":"0","endTime":"0","summary":"According to a research report from BOCOM INTL, the Hong Kong-listed healthcare sector charted an independent course in August, with the Hang Seng Healthcare Index climbing 9.3% against a 1.2%...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","ZECP","09939","159938","BK1161","BK1147","03329","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117075643","title":"Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1117075643","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117075643?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:12","pubTimestamp":1788484341,"startTime":"0","endTime":"0","summary":"According to the latest disclosure from the Hong Kong Stock Exchange, a notable change in share custody was recorded on September 3rd for GENFLEET-B (02595). The total market value of the shares held...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","02595","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664028698","title":"Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664028698","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664028698?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:07","pubTimestamp":1788473269,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group obtained investigational new drug approval for TQB6426 from the U.S. Food and Drug Administration.The drug is intended for advanced malignant tumors, according to a Thursday Hong Kong bourse filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","HK0000165453.HKD","BK1589","IE00BZ08YR35.GBP","BK1521","BK4588","BK4585","LABU","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118066289","title":"Baiyunshan Announces Cash Dividend Distribution for First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1118066289","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118066289?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:41","pubTimestamp":1788446515,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (also known as BAIYUNSHAN PH) disclosed on September 3 that it will execute its interim dividend payout for the 2026 fiscal first...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0097","BK1191","BK0012","BK0070","BK0096","600332","BK0028","BK1521","BK0183","BK1606","BK0188","BK0175","BK0196","BK1197","00874","BK1515","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033874","title":"Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033874","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033874?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:39","pubTimestamp":1788439175,"startTime":"0","endTime":"0","summary":"Sino Biopharm says FDA clears IND for TQB6426 GPC3 ADC trial in advanced tumorsFDA granted IND clearance for TQB6426, a GPC3-targeting antibody-drug conjugate from Sino Biopharmaceutical’s Chia Tai Ti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL2vynvZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YR35.GBP","01177","BK1589","IE00BZ08YS42.EUR","BK1521","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874083","title":"Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 \"Gpc3 ADC\" Approved by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874083?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:39","pubTimestamp":1788439159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V15X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01177","BK1191","HK0000165453.HKD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1589","BK1515","IE00BZ08YR35.GBP","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188828400","title":"Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1188828400","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188828400?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:34","pubTimestamp":1788435276,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on September 1, Wang Lei increased his holdings in CHINA RES MIXC (01209) by 50,000 shares. The transaction was executed at a price of HKD 38.52 per...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","HK0000165453.HKD","LU0456827905.SGD","01209","LU0164939612.USD","LU0082770016.USD","EWH","BK1571","BK1501","LU0082770016.SGD","00241","BK1610","BK1189","BK1617","BK1142","BK1589","BK1615","LU0620787316.HKD","LU0456846285.SGD","BK1515","BK1502","BK1584","BK1542","BK1258","BK1591","BK1583","BK1229","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101393084","title":"GENFLEET-B Allocates HK$546,400 to Buy Back 20,000 Shares on September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1101393084","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101393084?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:24","pubTimestamp":1788434654,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 3, 2026, it spent HK$546,400 to repurchase 20,000 of its own shares.This buyback reflects the company's ongoing capital management strategy, as it...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159938","02595","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878952","title":"Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878952?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:20","pubTimestamp":1788427213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0188","BK0196","BK0096","BK0028","BK0187","BK0183","BK1191","BK1593","BK0175","BK0012","BK0060","BK0239","600196","02196","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878574","title":"Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878574","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878574?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:18","pubTimestamp":1788427127,"startTime":"0","endTime":"0","summary":"Sihuan Pharma affiliate Xuanzhu Biopharm grants Innobic exclusive Thailand commercialization rights for Bireociclib tabletsSihuan Pharmaceutical’s non-wholly owned unit Xuanzhu Biopharm granted exclus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL8K9jwT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1191","BK1515","02575","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827084","title":"CSPC Pharmaceutical Group Stock Climbs 4.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827084","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827084?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rallied 4.8% to 9.61 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.The stock's rise snapped a four-day losing streak.CSPC Pharmaceutical Group Ltd. closed 17% below its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 6.3%, SSY Group Ltd. rose 0.2%, and United Laboratories International Holdings Ltd. rose 0.1%.Trading volume totaled 134.9 million shares, compared to the 50-day average of 105.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","LU1813983027.USD","IE00BZ08YR35.GBP","LU1226287875.USD","LU1807302812.USD","IE00BZ08YS42.EUR","LU1152091168.USD","LU0880133367.SGD","LU1152091754.HKD","01093","IE0008369823.USD","LU1951186391.HKD","IE0008368742.USD","LU0326950275.SGD","LU0072913022.USD","IE00B5MMRT66.SGD","LU1328277881.USD","IE00B031HY20.USD","BK1521","IE00B543WZ88.USD","LU0140636845.USD","LU1993786604.SGD","HK0000165453.HKD","LU1226287529.USD","LU1226287792.SGD","LU0501845795.SGD","LU0315179316.USD","BK1515","LU1960683339.HKD","LU0314109678.HKD","LU1008478684.HKD","LU1226288253.USD","SG9999004220.SGD","LU1226288170.HKD","IE00BZ08YT58.USD","LU0067412154.USD","BK1191","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664482770","title":"Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664482770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664482770?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 6.3% to 5.59 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.Sino Biopharmaceutical Ltd. closed 39% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 4.8% and Amgen Inc. remained unchanged.Trading volume totaled 127.7 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4585","PJP","LU0868494617.USD","LU0109394709.USD","LU0122379950.USD","IE0002141913.USD","IE00BZ08YS42.EUR","IE0009355771.USD","AMGN","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4533","LU0289739699.SGD","HK0000165453.HKD","IBB","BK1589","BK4588","IE00B4R5TH58.HKD","TBXU","IE00BJJMRZ35.SGD","LU1983299246.USD","BBH","BK4581","PBE","BK4566","LU1061106388.HKD","LU2242646821.SGD","IE00B2B36J28.USD","BK4534","01177","LU1571399168.USD","LU2089984988.USD","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","LU2112291526.USD","LU0320765992.SGD","LU1023059063.AUD","LU0889565916.HKD","BK1515","BK1521","BK4139","BK4599","IE00BZ08YR35.GBP","SG9999001440.SGD","BK1191","IBBQ","LU0058720904.USD","LU1057294990.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664038827","title":"BYD Electronic (International) Stock Falls 3.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664038827","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664038827?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. slipped 3.1% to 25.00 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.This was the stock's third consecutive day of losses.BYD Electronic  Co. Ltd. closed 44% short of its 52-week high of HK$44.60, which the company achieved Oct. 2.Despite its losses, the stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. fell 4.0%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 12.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00285","BK1504","BK1540","LU0348766576.USD","LU0348767384.USD","BK1580","BK1582","BK1589","LU0274383008.USD","BK1167","BK1607","BK1149","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168391109","title":"Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1168391109","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168391109?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:26","pubTimestamp":1788423987,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced that its majority-owned subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval from the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","600196","BK0188","BK0012","BK0175","BK0028","BK1191","BK1515","BK0239","02196","BK1593","BK0183","BK0060","BK0096","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199507474","title":"AH Premium Rankings Update: September 3 Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1199507474","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199507474?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:22","pubTimestamp":1788423720,"startTime":"0","endTime":"0","summary":"As of the close on September 3, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) occupy the top three positions in the AH premium rate rankings, with premium rates of 993.12%,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1554","HK0000352291.HKD","03130","IE00B29SXG58.USD","LU0862451753.SGD","LU1807302812.USD","LU0345780521.USD","LU0320764755.SGD","LU0880133367.SGD","SG9999002463.SGD","LU0531971595.HKD","02218","IE00B3M56506.USD","HK0000320264.USD","BK1503","LU0417516738.SGD","LU0588546209.SGD","00187","BK1564","03188","LU2394011477.USD","01033","LU1023057109.AUD","BK1574","IE00BVYPNQ40.USD","BK1551","LU0348766576.USD","LU1675838814.USD","LU2778985437.USD","LU0469268626.HKD","LU0049853897.USD","BK1592","02827","LU2177674079.SGD","SG9999004220.SGD","IE00BYV24P56.USD","LU1303224171.USD","BK1198","LU0287142896.SGD","00811","06185","BK1249","BK1506","BK1507","LU1211504680.USD","BK1147","LU0672654166.SGD","83188","BK1170","LU1244550221.USD","BK1514","LU2097828631.EUR","BK1593","IE00BF5LJ272.USD","LU1152091168.USD","SG9999001093.SGD","IE0032431581.USD","LU2039709279.SGD","LU0214875030.USD","LU1224709979.USD","BK1521","LU0052750758.USD","LU2294711473.HKD","LU1770034418.SGD","06826","LU0228659784.USD","BK1515","BK1163","01349","00300","BK1533","LU0082770016.USD","LU0828238088.HKD","LU0061477393.USD","BK1144","HK0000306701.USD","BK1522","159982","LU0327786744.USD","LU1244550494.USD","LU0348816934.USD","LU1481107354.HKD","BK1110","LU0561508036.HKD","LU0082770016.SGD","LU0456854461.SGD","LU0543330566.HKD","BK1141","IE00B031J352.USD","BK1214","LU0163747925.USD","LU2399975544.HKD","LU1242518857.USD","LU1961090484.USD","LU2097828474.EUR","LU1769817096.USD","LU0648948544.HKD","LU0502904849.HKD","BK1135","IE0008369823.USD","LU0329678170.USD","03750","BK1183","LU0315179316.USD","BK1202","IE00BVYPNP33.GBP","BK1223","LU1880383366.USD","LU0620787316.HKD","BK1191","LU0791590937.USD","LU0359201612.USD","LU0211977185.USD","399300","LU0348825331.USD","IE00BGHQDM52.EUR","LU0828237510.HKD","LU0540923850.HKD","LU1282649067.USD","LU2476274308.USD","LU0501845795.SGD","LU0456846285.SGD","03268","LU1046422090.SGD","LU1993786604.SGD","LU0173614495.USD","LU0165289439.USD","02338","LU0067412154.USD","BK1560","BK1125","LU1504937902.USD","LU0890818403.SGD","LU1366334651.USD","LU0140636845.USD","LU0370786039.SGD","BK1610","LU0359201885.HKD","LU0979878070.USD","82846","IE0008368742.USD","LU0640798160.USD","02692","SG9999011746.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU0828237940.HKD","LU1282649810.SGD","LU0488056044.USD","LU0051755006.USD","LU0254981946.USD","LU0531970944.HKD","LU0096374516.USD","LU1831875114.USD","LU0039217434.USD","LU0348788117.USD","LU0737861772.HKD","BK1149","LU0048580855.USD","LU2045819591.USD","LU2226246903.HKD","LU0348805143.USD","01057","LU0516422440.USD","LU0871576103.HKD","LU0348827113.USD","LU1794554557.SGD","BK1583","LU0509642566.USD","00991","LU1064131342.USD","LU0593848301.USD","LU0307460666.USD","BK1130","02009","BK1576","LU1152091754.HKD","LU0918141705.HKD","LU2097828557.USD","01108","IE00BMCWC346.EUR","LU0329678337.USD","BK1190","HK0000320223.HKD","HK0001040168.HKD","LU0149534421.HKD","LU0516422952.EUR","LU0231483743.USD","LU0868486357.SGD","LU0886674414.USD","06745","LU0634319403.HKD","SG9999014674.SGD","IE00BZ08YT58.USD","LU1048596156.SGD","IE00B031HY20.USD","LU1960683339.HKD","BK1594","83130","LU0266512127.USD","LU0345780281.USD","IE0034224299.USD","LU1282648689.USD","BK1562","LU0269904917.USD","LU0572944931.SGD","LU0128522157.USD","06869","07233","BK1563","LU0117841782.USD","IE00B543WZ88.USD","SG9999006597.SGD","BK1116","LU0359202008.SGD","SG9999001226.SGD","LU0823426480.USD","03308","LU0164939612.USD","00553","BK1544","BK1122","LU0823426308.USD","LU0229945570.USD","LU0210526637.USD","BK1546","EWH","LU0791591158.USD","LU0348735423.USD","LU1282649141.HKD","LU1115378108.SGD","LU0266512473.USD","LU0149721374.USD","HK0001040143.USD","02475","LU0918141887.USD","LU0228367735.SGD","LU1105468828.SGD","LU1688375341.USD","LU0043850808.USD","03328","SG9999002828.SGD","LU0516423174.USD","LU0431992006.USD","LU0106252389.USD","LU0456827905.SGD","BK1161","LU0164880469.USD","02846","LU0463099449.HKD","02359","03759","LU1188198961.HKD","01877","LU1880383440.USD","LU1808992512.USD","IE00B0169L03.USD","LU0543330483.HKD","01812","LU1255011170.USD","LU1251922891.USD","LU0328353924.USD","BK1231","LU0348767384.USD","BK1181","BK1237","LU1813983027.USD","LU0449509016.USD","LU1720050803.USD","LU0314109678.HKD","LU1244550577.SGD","LU0516423091.SGD","02691","03143","BK1530","LU1366334578.USD","LU0589944569.HKD","BK1523","LU0797268264.HKD","LU1242518931.SGD","LU2125910500.SGD","BK1505","LU0106959298.USD","LU0244354667.USD","LU0029875118.USD","LU0417516902.SGD","LU0072913022.USD","IE0031814852.USD","BK1171","LU1328277881.USD","02701","LU0348814723.USD","LU2008162690.USD","LU0164865239.USD","LU0737861699.HKD","LU0181495838.USD","03968","LU2476274720.SGD","LU0607220059.USD","03678","HK0000306685.HKD","LU1769817179.HKD","06821","LU0384037296.USD","03986","BK1105","LU0708995583.HKD","LU2097828805.USD","LU2242644610.SGD","02899","LU1655091616.SGD","LU0821914370.USD","LU0516422366.SGD","HK0000352382.USD","LU1719994722.HKD","IE00BZ08YR35.GBP","LU2097828714.EUR","LU3063872942.SGD","LU0320764599.SGD","LU0326950275.SGD","LU0455707207.USD","LU1988902786.USD","00568","LU2264538146.SGD","LU1008478684.HKD","00042","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664230488","title":"BYD Electronic Could See Earnings Inflection in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664230488","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664230488?lang=en_us&edition=fundamental","pubTime":"2026-09-03 11:15","pubTimestamp":1788405300,"startTime":"0","endTime":"0","summary":"0315 GMT - BYD Electronic could see an earnings inflection in 2027 thanks to areas such as liquid cooling and high-voltage power, says DBS Group Research's Jim Hin Kwong Au in a note. Artificial-intelligence infrastructure is likely to remain the main growth driver for the Chinese electric-component maker, he says. Its cold-plate project has ramped up mass production, the analyst says, noting the company is a core supplier of liquid cooling components for Nvidia. Power products are also likely to boost earnings, with BYDE using high-voltage technologies developed from its automotive business to target certain power architecture, he adds. DBS raises its target price to 40.00 Hong Kong dollars from HK$30.00 and maintains a buy rating. Shares decline 0.85% to HK$25.58.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1580","BK1607","LU0348766576.USD","BK1515","BK1582","LU0274383008.USD","BK1167","LU0348767384.USD","00285","BK1589","BK1504","BK1540","BK1149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128427781","title":"Clinical Data Readouts Take Center Stage as Chinese Biotech Firms Surge; CSPC Pharma Climbs Over 4% While Huabao's HK Biotech ETF Holds Key Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1128427781","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128427781?lang=en_us&edition=fundamental","pubTime":"2026-09-03 11:00","pubTimestamp":1788404450,"startTime":"0","endTime":"0","summary":"Hong Kong-listed innovative drug stocks continued their upward momentum on September 3rd, with leading biotech names pushing the sector higher. CSPC Pharma and Sino Biopharmaceutical both advanced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","520880","LU1813983027.USD","MEDX","HK0000165453.HKD","LU1152091168.USD","159316","LU1152091754.HKD","LU0072913022.USD","LU1226288170.HKD","LU0314109678.HKD","LU0501845795.SGD","06978","LU1328277881.USD","LU1226287792.SGD","IE0008369823.USD","LU1807302812.USD","IE00BZ08YT58.USD","IBBQ","KURE","BK1161","LU0140636845.USD","IE00B031HY20.USD","LU1226287875.USD","LU1960683339.HKD","LU1951186391.HKD","LU2039709279.SGD","LU0880133367.SGD","SG9999004220.SGD","IE00B543WZ88.USD","IE0008368742.USD","IE00BZ08YR35.GBP","01093","159992","LU1993786604.SGD","BK1521","LU0315179316.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","BK1191","LU1226288253.USD","LU0326950275.SGD","FLHK","LU1008478684.HKD","LU1226287529.USD","LNGR","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161196029","title":"SBP Group Surges Over 4% in Morning Trade on FDA Clearance for TQB6426","url":"https://stock-news.laohu8.com/highlight/detail?id=1161196029","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161196029?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:30","pubTimestamp":1788402647,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed nearly 5% during Tuesday's morning session, with the stock last trading up 4.47% at HK$5.50, on turnover of HK$154 million.The rally follows the announcement that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","BK1589","BK1515","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1191","LABU","BK4588","BK4585","HK0000165453.HKD","BK1521","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198828841","title":"CanSino Biologics' Global Revenue Soars 4,724% in First Half, Systemic Expansion Strategy Unlocks Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1198828841","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198828841?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:10","pubTimestamp":1788354651,"startTime":"0","endTime":"0","summary":"CanSino Biologics Inc. has released its interim report for the first half of 2026, revealing total revenue of RMB 550 million, a 43.81% increase year-on-year, alongside a significant narrowing of its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","06185","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":181,"code":"91000000","status":"200"}]}}